MAOB and glycogen storage disease VI: The method to identify Parkinson’s Disease by using dopaminergic drugs as proxy for Parkinson disease is highly specific since dopaminergic drugs are coupled with a Parkinson’s Disease reimbursement code and the combination of MAO-B, Levodopa and Dopamine Agonists is very specific to Parkinson Disease [10–12, 24, 28].